A Phase 3 Trial Comparing Bortezomib Plus Rituximab with Rituximab Alone In Patients with Relapsed, Rituximab-Naive or -Sensitive, Follicular Lymphoma

AuthID
 P-003-0Y3
19
Author(s)
Hong, XN
·
Scheliga, A
·
Mayer, J
·
Offner, FC
·
Rule, SA
·
Teixeira, A
·
Walewski, JA
·
Crump, M
·
Shpilberg, O
·
Hermann, R
·
Parasuraman, S
·
Zhu, E
·
Enny, C
·
Theocharous, P
·
van de Velde, H
·
Elsayed, Y
·
Zinzani, PL
Document Type
Abstract
Year published
2010
Published
in BLOOD, ISSN: 0006-4971
Volume: 116, Issue: 21, Pages: 373-374 (2)
Conference
52Nd Annual Meeting of the American-Society-Of-Hematology (Ash), Date: DEC 04-07, 2010, Location: Orlando, FL, Sponsors: Amer Soc Hematol
Indexing
Wos®
Publication Identifiers
Wos: WOS:000289662200858
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service